Merck

I5029

Sigma-Aldrich

IgG1, Lambda from human myeloma plasma

purified immunoglobulin, >95% (SDS-PAGE)

Sinónimos:
Human IgG1-λ
Número MDL:
NACRES:
NA.46

origen biológico

human

Nivel de calidad

conjugado

unconjugated

forma del anticuerpo

purified immunoglobulin

Análisis

>95% (SDS-PAGE)

enviado en

dry ice

temp. de almacenamiento

−20°C

¿Está buscando productos similares? Visit Guía de comparación de productos

Comparar elementos similares

Ver comparación completa

Show Differences

1 of 4

Este artículo
M6034I5154I5654
conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

antibody form

purified immunoglobulin

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

shipped in

dry ice

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

storage temp.

−20°C

assay

>95% (SDS-PAGE)

assay

-

assay

>95% (SDS-PAGE)

assay

>90% (microfluidic capillary gel electrophoresis)

Descripción general

IgG antibody subtype is the most abundant serum immunoglobulins of the immune system. It is secreted by B cells and is found in blood and extracellular fluids and provides protection from infections caused by bacteria, fungi and viruses. Maternal IgG is transferred to fetus through the placenta that is vital for immune defence of the neonate against infections. IgG1 is the most abundant of the IgG subclass
Human myeloma IgG1, λ is purified from human plasma by fractionation, ion-exchange, and affinity chromatography procedures.
IgG is the main antibody type found in plasma and extracellular fluid and is expressed on B cell membrane. IgG is further subdivided into four subclass- IgG1, IgG2, IgG3 and IgG4.Elevation in antigen specific IgG1 is associated with symptomatic infection and Th2-regulation. IgG1 λ from human myeloma can be used in quantitative ELISA.Human IgG1 λ react specifically with human IgG.

Aplicación

IgG1 λ from human myeloma can be used as reference antigen, blocking agent, immunoglobulin calibrator or coating protein in various immunoassay like ELISA, dot blot immunobinding, immunodiffusion, immunoelectrophoresis, hemagglutination, cell-binding assays and western immunoblotting.
The purified IgG1, λ may be used as an immunoglobulin calibrator, reference antigen, blocking agent or coating protein in a variety of immunoassays including ELISA, dot-blot immunobinding, Western immunoblotting, immunodiffusion, immunoelectrophoresis, hemagglutination, and cell-binding assays. Human myeloma IgG1, λ was used as non-specific control in quantitative ELISA and solid-phase ELISA. A range of concentrations of IgG1, λ from 10 to 100 ng was used for quantitative ELISA. Human myeloma IgG1, λ was also used as control in size-exclusion chromatography to analyse purity of recombinant antibodies.

Forma física

Solution in 0.02 M Tris buffered saline, pH 8.0.

Nota de análisis

Identity is determined by immunoelectrophoresis and indirect ELISA.

Cláusula de descargo de responsabilidad

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Código de clase de almacenamiento

10 - Combustible liquids

WGK

WGK 1

Punto de inflamabilidad F

Not applicable

Punto de inflamabilidad C

Not applicable


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Documents related to the products that you have purchased in the past have been gathered in the Document Library for your convenience.

Visit the Document Library

Difficulty Finding Your Product Or Lot/Batch Number?

Las referencias de los producto se combinan con los tamaños de envase y las cantidades cuando se muestran en la página web, por ejemplo: T1503-25G. Asegúrese de introducir el número de producto ÚNICAMENTE en el campo del Número de producto (Ejemplo T1503).

Ejemplo

T1503
Referencia del producto
-
25G
Tamaño del envase/cantidad

Otros ejemplos

705578-5MG-PW

PL860-CGA/SHF-1EA

MMYOMAG-74K-13

1000309185

introducir como1.000309185)

¿Tiene algún problema? No dude en ponerse en contacto con nosotros Servicio técnico para asistencia

Lot and Batch Numbers can be found on a product's label following the words 'Lot' or 'Batch'.

Productos Aldrich

  • Si encuentra un número de lote como TO09019TO, introduzca el número de lote 09019TO sin las dos primeras letras.

  • Si encuentra un número de lote con un código de entrada como 05427ES-021, introduzca el número 05427ES sin el código de entrada -021.

  • Si encuentra un número de lote con un código de entrada como STBB0728K9, introduzca el código de lote STBB0728 sin el código de entrada K9.

¿No ha encontrado lo que estaba buscando?

En algunos casos, puede que un COA no esté disponible en la página web. Si su búsqueda no encontró el COA puede solicitarlo.

Solicitar COA

W L Zhao et al.
Journal of the European Academy of Dermatology and Venereology : JEADV, 36(2), 271-278 (2021-10-28)
The detection of serum anti-desmoglein (Dsg) IgG autoantibodies has been reported to be useful for assessment of disease activity in pemphigus. However, previous studies have reported that anti-Dsg autoantibodies remain detectable in some patients without active pemphigus lesions. To investigate
Cristina Capodicasa et al.
Plant biotechnology journal, 9(7), 776-787 (2011-01-27)
There is an increasing interest in the development of therapeutic antibodies (Ab) to improve the control of fungal pathogens, but none of these reagents is available for clinical use. We previously described a murine monoclonal antibody (mAb 2G8) targeting β-glucan
Targeting CD70 in combination with chemotherapy to enhance the anti-tumor immune effects in non-small cell lung cancer.
Flieswasser, et al.
Oncoimmunology, 12, 2192100-2192100 (2023)
M J Day
Veterinary parasitology, 147(1-2), 2-8 (2007-05-01)
Infection with Leishmania may have different outcomes in genetically distinct individuals and the course of infection is determined by the nature of the host innate and adaptive immune response. Thus in experimentally infected mice, and in naturally infected dogs or
Julie Jacobs et al.
Oncotarget, 8(43), 74058-74067 (2017-11-02)
In contrast to the negligible expression of the immunomodulating protein CD70 in normal tissue, we have demonstrated constitutive overexpression of CD70 on tumor cells in a subset of primary non-small cell lung cancer (NSCLC) biopsies. This can be exploited by

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico